The pathophysiology of IBD is characterized by elevated levels of cytokines such as IL‐6, IL‐22, and IL‐23, which serve as ligands for cell surface receptors, leading to STAT3 activation [96, 97]. Here, STAT3 is linked to inflammatory bowel disease.